PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+7.24%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$7.28B
AUM Growth
+$7.28B
(+11%)
Cap. Flow
+$353M
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
22.14%
Holding
282
New
28
Increased
103
Reduced
67
Closed
44
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$129M |
| 2 |
Medtronic
MDT
|
$70.6M |
| 3 |
Becton Dickinson
BDX
|
$54M |
| 4 |
RTX Corp
RTX
|
$52.4M |
| 5 |
Humana
HUM
|
$47M |
Top Sells
| 1 |
Merck
MRK
|
$82.5M |
| 2 |
Baxter International
BAX
|
$49.3M |
| 3 |
Incyte
INCY
|
$41.9M |
| 4 |
Boston Scientific
BSX
|
$34.9M |
| 5 |
Stryker
SYK
|
$34.6M |
Sector Composition
| 1 | Financials | 23.88% |
| 2 | Healthcare | 23.8% |
| 3 | Technology | 20.4% |
| 4 | Communication Services | 10.37% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Fidelity National Information Services
FIS
$35.6B
| $25.4M | 0.34% |
297,270
| – | – |
|
102
Carnival Corp
CCL
$42.5B
| $25.3M | 0.34% |
386,074
| – | – |
|
|
MDSO
103
DELISTED
Medidata Solutions, Inc.
MDSO
| $25.2M | 0.34% |
321,996
-52,696
| -14% | -$4.12M |
|
104
Lam Research
LRCX
$124B
| $24.9M | 0.34% |
1,759,940
-47,000
| -3% | -$665K |
|
105
Freeport-McMoran
FCX
$66.3B
| $23.8M | 0.32% |
1,985,501
+274,410
| +16% | +$3.3M |
|
|
TLND
106
DELISTED
Talend S.A. American Depositary Shares
TLND
| $23.6M | 0.32% |
679,860
-113,520
| -14% | -$3.95M |
|
107
RingCentral
RNG
$2.74B
| $23.6M | 0.32% |
645,873
-253,555
| -28% | -$9.26M |
|
|
MIME
108
DELISTED
Mimecast Limited
MIME
| $23.4M | 0.31% |
+872,353
| New | +$23.4M |
|
109
8x8 Inc
EGHT
$270M
| $23.2M | 0.31% |
1,598,630
+205,300
| +15% | +$2.98M |
|
|
EVBG
110
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $22.8M | 0.31% |
936,976
+118,635
| +14% | +$2.89M |
|
111
Pegasystems
PEGA
$9.22B
| $22.7M | 0.31% |
779,972
-438,756
| -36% | -$12.8M |
|
112
BioMarin Pharmaceuticals
BMRN
$11.3B
| $22.2M | 0.3% |
244,211
-238,089
| -49% | -$21.6M |
|
|
AXDX
113
DELISTED
Accelerate Diagnostics
AXDX
| $22M | 0.3% |
+80,497
| New | +$22M |
|
|
QTNT
114
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $21.9M | 0.3% |
+74,500
| New | +$21.9M |
|
|
QVCGA
115
QVC Group, Inc. Series A Common Stock
QVCGA
$65.8M
| $21.6M | 0.29% |
18,152
-549
| -3% | -$654K |
|
116
ProAssurance
PRA
$1.22B
| $21.3M | 0.29% |
351,100
+2,800
| +0.8% | +$170K |
|
117
MACOM Technology Solutions
MTSI
$9.69B
| $21.1M | 0.28% |
+377,700
| New | +$21.1M |
|
118
FIVE9
FIVN
$2.05B
| $20.4M | 0.27% |
949,272
-619,151
| -39% | -$13.3M |
|
|
ALXN
119
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $20M | 0.27% |
164,712
-273,522
| -62% | -$33.3M |
|
|
120
Merck
MRK
$210B
| $19.5M | 0.26% |
318,871
-1,348,289
| -81% | -$82.5M |
|
|
XYZ
121
Block, Inc.
XYZ
$46.2B
| $19.3M | 0.26% |
824,199
+554,820
| +206% | +$13M |
|
122
Lumentum
LITE
$9.37B
| $19.3M | 0.26% |
+338,795
| New | +$19.3M |
|
|
PTLA
123
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $19M | 0.26% |
+337,500
| New | +$19M |
|
124
Texas Instruments
TXN
$178B
| $18.5M | 0.25% |
241,116
| – | – |
|
125
HCA Healthcare
HCA
$95.4B
| $17.5M | 0.24% |
200,908
+111,908
| +126% | +$9.75M |
|